Transport of Adoptive Cell Transfers With Magnetic Helical Microrobots
Ritu R Raj1, Nicole B Day1, Nichole E Loomis1
1Department of Chemical and Biological Engineering, University of Colorado Boulder, Boulder, CO, 80303, USA.
Small (Weinheim an Der Bergstrasse, Germany)
|September 5, 2025
Summary
Magnetically controlled microrobots deliver therapeutic cells through mucus barriers. These drug-eluting helical robots maintain cell function, offering a novel approach for treating inflammatory diseases.
Area of Science:
- Biomedical Engineering
- Materials Science
- Cellular Biology
Background:
- Adoptive cell transfers (ACTs) show promise for treating inflamed tissues but face delivery challenges through biological barriers like mucus.
- Maintaining the therapeutic function and phenotype of transferred cells in diseased microenvironments is a significant hurdle.
Purpose of the Study:
- To investigate the use of magnetically controlled helical microrobots for transporting macrophages through mucus.
- To assess the ability of these microrobots to maintain macrophage function and phenotype via drug elution.
Main Methods:
- Fabrication of nickel-titanium coated helical microrobots using two-photon lithography and sputter coating.
- Embedding microrobots with dexamethasone for sustained drug release.
- Investigating macrophage attachment to microrobots and analyzing cell-helix complex trajectories under rotating magnetic fields.
- Comparing transport efficiency in aqueous solutions versus artificial mucus.
Main Results:
- Successful attachment of macrophages to helical microrobots.
- Demonstrated nonzero velocity of cell-helix complexes in viscous artificial mucus.
- Confirmed no loss of macrophage viability after magnetic actuation.
- Observed directed polarization of macrophages towards an anti-inflammatory phenotype due to dexamethasone release.
Conclusions:
- Magnetically controlled helical microrobots can effectively transport macrophages through mucus barriers.
- Sustained drug elution from microrobots preserves macrophage viability and promotes a therapeutic phenotype.
- This system presents a proof-of-concept for advanced cell delivery strategies in inflammatory disease treatment.


